AzTrials
AzTrials

Labor PainPhase 2/3NCT01687933

The Effect of Virtual Reality Glasses on Labor Pain

A Phase 2/3 study testing three-dimensional glasses(manufactor Vuzix,wrap 920) in people with Labor Pain and Anxiety, run by Mashhad University of Medical Sciences.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

There are different medicinal and non medicinal methods to control labor pain. Today, much attention has been on non medicinal methods because of limitations and complications of medical procedures. Virtual reality is a new and promising method of diversion of mind that may have an impact on labor pain. Read more about this study

Who is it for?
Ages 18 to 29 years, women onlyHealthy volunteers can take part
Conditions the study is for
Labor Pain, Anxiety
What is being tested?
three-dimensional glasses(manufactor Vuzix,wrap 920)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
No sites listed yet
Study dates
Feb 2011to Aug 2012
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Iranian
  • low risk pregnancy
  • primipara

Who cannot join

  • vision or ear disorders
  • History of motion sickness or headaches
  • psychological disease or Addiction

About this study

Official title: Principal Investigator

There are different medicinal and non medicinal methods to control labor pain. Today, much attention has been on non medicinal methods because of limitations and complications of medical procedures. Virtual reality is a new and promising method of diversion of mind that may have an impact on labor pain. This study was conducted to determine the effect of virtual reality on the first stage of labor pain.

Conditions
Labor Pain, Anxiety
Being tested
three-dimensional glasses(manufactor Vuzix,wrap 920), usual care
Keywords
Labor pain, Virtual reality, the first stage of labor, Pain relief, Simulator
Medical subject headings
Labor Pain, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • three-dimensional glasses(manufactor Vuzix,wrap 920)Device

    The samples were randomly allocated to use three-dimensional glasses for 30 minutes in order to reliving labor pain.

  • usual careOther

    Women in Control group did not use the glasses.

Study groups in NCT01687933
Study groupRoleWhat they receive
three-dimensional glasses (Virtual Reality glasses)ExperimentalWomen in case group used the glasses for 30 minutes
Receives: Device: three-dimensional glasses(manufactor Vuzix,wrap 920)
usual careExperimentalWomen in control group did not use the glasses.
Receives: Other: usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain and anxiety

    Measured: up to 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Sep 2012 (estimated)
  2. Study startFeb 2011
  3. Primary completionJul 2012
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01687933
Sponsor's protocol ID
Virtual Reality System
Status last verified
Aug 2012
First submitted
29 Aug 2012
Last updated
19 Sep 2012
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing three-dimensional glasses(manufactor Vuzix,wrap 920) in people with Labor Pain and Anxiety, run by Mashhad University of Medical Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2012. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain and anxiety (time frame: up to 8 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in